Cathelijne de Gram
Cathelijne de Gram is EU Regulatory Policy Leader at J&J Innovative Medicine.
JournalAn industry perspective on the use of patient experience data in medicines development: Is further action needed from European regulators?
Engaging with patients to understand their experiences, needs and preferences provides important information to sponsors of medicines development as well as to decision-makers, and integrating this information into every stage of medical product development can significantly enhance the therapeutic landscape for all stakeholders.